Related Experiment Video

Updated: May 6, 2026

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

4.2K

Editorial: molecular targeting for development of novel therapeutic strategies in brain diseases: myth or reality?)

Jean F Soustiel1

  • 1Department of Neurosurgery Western Galilee Hospital Naharia and Galilee Faculty of Medicine Bar Ilan University Zafed Israel.. jean.soustiel@naharia.health.gov.il.

CNS & Neurological Disorders Drug Targets
|October 31, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.3K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.3K

Related Experiment Videos

Last Updated: May 6, 2026

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

4.2K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.3K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
The Blood-brain Barrier00:49

The Blood-brain Barrier

47.4K
Overview
47.4K

Articles linked to this work by shared authors, journal, and citation graph.

Simvastatin-induced neuroprotective effect after brain injury is mediated by mitochondrial protection through modulation of the 18 ​kDa translocator protein.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025

Mitochondrial translocator-protein ligand etifoxine reduces pain symptoms and protects against motor dysfunction development following peripheral nerve injury in rats.

Neuropharmacology·2025

Skull base hemangiopericytomas.

Acta neurologica Belgica·2021

Post-traumatic cytotoxic edema is directly related to mitochondrial function.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2015

Syria civil war: Outcomes of humanitarian neurosurgical care provided to Syrian wounded refugees in Israel.

Brain injury·2015

Clinical applications of intracranial pressure monitoring in traumatic brain injury : report of the Milan consensus conference.

Acta neurochirurgica·2014

Mechanistic Evaluation of Psilocybin in Neurodegenerative Disorders: Relevance of 5-HT2A Receptors and Downstream Pathways.

CNS & neurological disorders drug targets·2026

From Hypothesis to Clinical Validation: A Bibliometric Mapping of Immunotherapy for Neurodegenerative Proteinopathies (2000-2025).

CNS & neurological disorders drug targets·2026

Overview of the Mechanistic Potential of Serotonin Reuptake Transporters in Depression.

CNS & neurological disorders drug targets·2026

Unraveling Shared Molecular Mechanisms in Alzheimer's, Parkinson's, and Neuropathic Pain: Targeting p38 MAPK and Wnt/β-Catenin Pathways.

CNS & neurological disorders drug targets·2026

Aging-driven Mechanisms Underlying Parkinson's Disease Pathogenesis: Molecular, Cellular, and Systemic Perspectives.

CNS & neurological disorders drug targets·2026

Prolactin and Neuroendocrine Regulation in Brain Injury: Mechanisms of Adaptive Plasticity and Therapy Strategies.

CNS & neurological disorders drug targets·2026

Hybrid exosome-liposome nanovesicles as delivery platforms for therapeutic applications: merging the best of both worlds.

Theranostics·2026

A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation.

Theranostics·2026

An inducible human LDLR transgenic mouse model for enhanced lentiviral gene delivery to murine immune cells.

Frontiers in immunology·2026

Transcranial ultrasound stimulation of the right globus pallidus interna in schizophrenia: A randomized, sham-controlled pilot study.

NPJ acoustics·2026

Case report: Clinical utility and limitations of high-frequency ultrasound for monitoring sonidegib response in nodular basal cell carcinoma: a three-case series.

Frontiers in oncology·2026

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

Haematologica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us